Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I think had it not for CYDY to have been so many m

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153898
(Total Views: 544)
Posted On: 02/24/2021 6:24:53 PM
Posted By: onestepahead
Re: Borel Fields #79748
I think had it not for CYDY to have been so many months into the cd-12 trial with management knowing that the odds were with them for full approval that it coulda been unblinded at 50% and EUA was there for the taking but it would have stopped the trial and EUA only. I strongly believe that CYDY wanted the path of least resistance in letting the data speak for itself vs have to get any any kind of on the fence decision on EUA. Nadar stated prob 15 times in the past year it’s a phase 3 study we hit the PE and we get approval unlike taht of cd-10 I think he used the term “exploratory trial for cd-10” I also think that there is a longer term view that full approval would give open label use to a whole array of different populations of covid and other indications. I am glad that they went beyond 50% and bypassed 75%. Were less than a couple weeks away from letting the world know CYDY is a game changer that has a covid-19 life saving drug. Many of us longs have known it for awhile, ans Nadar is Eager to make the data and reports public as soon as confidential discussions with FDA Health Canada MHRA are concluded. Going by what we have seen many therapeutics granted EUA on may be beneficial and benefits outweigh the risks this is a no brainer so the confidential discussions have to be all positive regarding EUA distribution, allotment, manufacturing ramp up, OWS, government grants from UK etc, what patients would be eligible to receive leronlimab? Same as in OLE or EIND or slightly different now that they have all cd-12 data. Will EUA be applied for or just given? Will they skip the whole EUA process and give full approval if Pvalue was met? Many positive things to think but can’t think of 1 reason why 3-4 different countries wanting to speak up CYDY if the drug was not a success. Cant wait to also here some news and media attention to long haulers which should be injecting first patients and prob majority of trail within early March than 8 weeks after results for that trail can be gathered. Exciting times, stressful but exciting


(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us